Highview Capital Management LLC DE Has $1.32 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Highview Capital Management LLC DE lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 29.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,523 shares of the healthcare conglomerate's stock after selling 1,068 shares during the quarter. Highview Capital Management LLC DE's holdings in UnitedHealth Group were worth $1,321,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of UNH. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $41,000. Finally, Copia Wealth Management acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $42,000. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on UNH shares. Mizuho lowered their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Truist Financial restated a "buy" rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Finally, Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $415.57.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $3.79 during trading on Tuesday, reaching $307.50. The company's stock had a trading volume of 9,600,755 shares, compared to its average volume of 7,574,032. The business's 50-day moving average price is $322.66 and its 200-day moving average price is $445.65. The firm has a market cap of $278.95 billion, a PE ratio of 12.88, a P/E/G ratio of 1.48 and a beta of 0.45. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.87%. UnitedHealth Group's payout ratio is presently 37.02%.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer directly owned 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.